These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8124846)

  • 21. Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.
    Wilmer WA; Hebert LA; Lewis EJ; Rohde RD; Whittier F; Cattran D; Levey AS; Lewis JB; Spitalewitz S; Blumenthal S; Bain RP
    Am J Kidney Dis; 1999 Aug; 34(2):308-14. PubMed ID: 10430979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy.
    You H; Gao T; Cooper TK; Morris SM; Awad AS
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F447-55. PubMed ID: 26041444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].
    Hay U; Ludvik B; Gisinger C; Schernthaner G
    Schweiz Med Wochenschr; 1988 Feb; 118(5):165-9. PubMed ID: 3278375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of captopril on diabetic nephropathy in hypertensive women.
    Gonzalez-Sicilia de Llamas L; Garcia Alberola A; Lafuente Lopez-Herrera M; Fuente Jimenez T; Fernandez Pardo J; Hernandez Cascales J
    Eur J Clin Pharmacol; 1991; 41(5):405-9. PubMed ID: 1761066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
    Insua A; Ribstein J; Mimran A
    Postgrad Med J; 1988; 64 Suppl 3():59-62; discussion 90-2. PubMed ID: 3074298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.
    Lenz T; August P
    Wien Klin Wochenschr; 1990 May; 102(11):315-9. PubMed ID: 2195780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome.
    Hod M; van Dijk DJ; Karp M; Weintraub N; Rabinerson D; Bar J; Peled Y; Erman A; Boner G; Ovadia J
    Nephrol Dial Transplant; 1995 Dec; 10(12):2328-33. PubMed ID: 8808235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.
    Larsen M; Hommel E; Parving HH; Lund-Andersen H
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):505-9. PubMed ID: 2265765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Angiotensin-converting enzyme inhibitors in the treatment of diabetic nephropathy].
    Sawicki PT; Mühlhäuser I; Berger M
    Dtsch Med Wochenschr; 1994 Sep; 119(38):1298-9. PubMed ID: 7924925
    [No Abstract]   [Full Text] [Related]  

  • 30. Captopril and diabetic nephropathy.
    Lewis EJ
    JAMA; 1995 Jun; 273(23):1831. PubMed ID: 7776492
    [No Abstract]   [Full Text] [Related]  

  • 31. Captopril in diabetic nephropathy.
    Fong M; Hart LL
    DICP; 1990 Mar; 24(3):260-1. PubMed ID: 2180219
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensin-converting enzyme inhibitors in diabetic nephropathy.
    Melchior WR; Bindlish V; Jaber LA
    Ann Pharmacother; 1993 Mar; 27(3):344-50. PubMed ID: 8384031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical trials of ACE inhibitors and ARB for treatment of patients with hypertension, heart failure, and diabetic nephropathy in Japan--special reference to the dosage schedule and adverse effects].
    Kageyama S
    Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):180-1. PubMed ID: 18421844
    [No Abstract]   [Full Text] [Related]  

  • 34. Captopril, blood pressure, and diabetic nephropathy.
    Sawicki PT; Mühlhauser I; Berger M
    JAMA; 1994 Oct; 272(13):1005. PubMed ID: 8089882
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
    Thöne-Reinke C; Simon K; Richter CM; Godes M; Neumayer HH; Thormählen D; Hocher B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
    Roozbeh J; Banihashemi MA; Ghezlou M; Afshariani R; Salari S; Moini M; Sagheb MM
    Ren Fail; 2010 Jan; 32(2):172-8. PubMed ID: 20199178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review.
    Strippoli GF; Craig M; Deeks JJ; Schena FP; Craig JC
    BMJ; 2004 Oct; 329(7470):828. PubMed ID: 15459003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
    Mathiesen ER; Hommel E; Giese J; Parving HH
    BMJ; 1991 Jul; 303(6794):81-7. PubMed ID: 1860008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging trends for prevention and treatment of diabetic nephropathy: blockade of the RAAS and BP control.
    Hunsicker LG
    J Manag Care Pharm; 2004 Sep; 10(5 Suppl A):S12-7. PubMed ID: 15369420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.